Search results

Selected filters:

Transactions
News

Article type

Topic

Sector

Regions

Year

461 results found for your search

Sort options
03 October 2019

For start-ups, patents should be a means to an end, not an end in themselves

Investing in IP may be necessary for early-stage businesses, but there are plenty of circumstances when the money is better spent elsewhere

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

12 September 2019

Huawei CEO: our 5G IP can be had for an upfront fee

Ren Zhengfei welcomes telecom equipment competition with a grandiose offer, but some key details are still open to question

11 September 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience

07 September 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up

28 August 2019

Asia's top IP owners revealed

Big filers, tough litigators and savvy dealmakers identified across eight industries in the run-up to IPBC Asia in Tokyo this October

24 August 2019

Adversaries no more - licensors look to make deals, not settlements

In its day, the IPNav model was hugely successful in generating cash, but successful licensing in the here and now requires a different, less confrontational approach

21 August 2019

US removes 5G work exemption from Huawei ban

The Commerce Department extended Huawei’s temporary licence yesterday, but it dropped a provision that allowed technology sharing as part of 5G standards development

07 August 2019

Image, ownership and an app made in St Petersburg

The IP issues raised by the use of FaceApp have been largely ignored. They should not be

03 August 2019

Life sciences IP – the major developments in July

All the big pharma and biotech patent stories from last month in our regular monthly round-up

27 July 2019

Apple's Intel purchase is a big win for both sides

In the era of patents plus dealmaking, the iPhone giant's acquisition of the chipmaker's modem business is a perfect example of the type

17 July 2019

Despite huge potential, patent operations at Chinese universities lag international standards

Technology transfer and commercialisation are buzzwords in China and attract more attention everyday. But before widespread IP-based private-public partnerships develop, there are significant systemic hurdles to overcome

10 July 2019

Intel takes patents off market and enters exclusive talks with potential buyer

Acquirer not named, but Apple looks like a strong candidate to purchase the portfolio of 8,500 largely unencumbered wireless assets that was due to be auctioned in August

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month